Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality.
about
Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary diseaseSystemic corticosteroids for acute exacerbations of chronic obstructive pulmonary diseaseSelf management for patients with chronic obstructive pulmonary diseaseExacerbations of COPDRoflumilast: a review of its use in the treatment of COPDNatural history of COPD: Focusing on change in FEV1Chronic obstructive pulmonary disease: respiratory review of 2013Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseCorticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary diseaseA critical review of recent developments in radiotherapy for non-small cell lung cancerTemporal disease trajectories condensed from population-wide registry data covering 6.2 million patientsImproving quality of care for end-stage respiratory disease: Changes in attitude, changes in service.The effects of theophylline on hospital admissions and exacerbations in COPD patients: audit data from the Bavarian disease management program.Rehabilitation of Discharged Patients With Chronic Obstructive Pulmonary Disease-Are New Strategies Needed?Hospital readmissions for COPD: a retrospective longitudinal study.Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012-2013.Cigarette smoke exposure exacerbates lung inflammation and compromises immunity to bacterial infection.The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients.Impact of Integrated Care Model (ICM) on Direct Medical Costs in Management of Advanced Chronic Obstructive Pulmonary Disease (COPD).An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial.Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease.Airway epithelial platelet-activating factor receptor expression is markedly upregulated in chronic obstructive pulmonary disease.Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation.Predictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study.Impact of multimorbidity on disability and quality of life in the Spanish older populationBTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults.An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment.In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based studyThe impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort studyStandards of suitability for the management of chronic obstructive respiratory diseasesIndacaterol for chronic obstructive pulmonary disease: systematic review and meta-analysisCharacterisation and prognosis of undiagnosed chronic obstructive pulmonary disease patients at their first hospitalisation.Targeting IL-1β and IL-17A driven inflammation during influenza-induced exacerbations of chronic lung inflammationLength of stay of COPD hospital admissions between 2006 and 2010: a retrospective longitudinal study.Prediction of COPD-specific health-related quality of life in primary care COPD patients: a prospective cohort study.Prophylactic use of macrolide antibiotics for the prevention of chronic obstructive pulmonary disease exacerbation: a meta-analysis.Seasonality, ambient temperatures and hospitalizations for acute exacerbation of COPD: a population-based study in a metropolitan areaInflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer.Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study.Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records
P2860
Q24187361-33DA912F-7521-4CDC-9708-66B21806E9F7Q24193908-47055B09-7D57-4EB1-94C0-DEE35EABE652Q24197903-E7345790-5818-412E-BB98-7008CB036785Q26764891-26264F3F-B734-45C7-B534-CC55F6D3463FQ26770501-4653DF86-B143-42F8-9C0A-79CB6B17F5BEQ26801417-C611360C-0ACB-44EE-A1B0-5B564C970662Q26864703-FB934A68-B97A-4E9F-994E-3FE0E80D3FBBQ27000043-127DED9F-0010-4743-B96D-D8078FBAC9EAQ27023118-3150995E-FCBF-4613-AEA3-D127239EFD88Q28079625-D0A7597C-A86B-4607-B257-127E20BE76D0Q30002373-6BF17170-71FD-4A26-982F-DD72740436F2Q30401869-0A7081C7-FA04-4818-915E-EFADE07D3709Q30820703-98C8B598-5AEA-4328-880C-EC733CE67288Q33633132-74414EDC-51DF-43DA-A4A2-AD116E129977Q33698677-A3E9411D-87CF-4776-9127-392D6D7D15A7Q33754147-47988F94-39C8-4ED3-A9CE-0D78A9D19CE8Q33790352-C8919622-7638-407F-B72B-CE675A6DE232Q33817770-65C08C02-D232-4E5D-BA15-002943024214Q33818662-09095317-5167-43C9-A2D9-98C82527F265Q33861510-E2883447-E2EF-46AF-8C98-A61B5C0F25B0Q34042468-0E184B2A-1179-4A00-B841-A49E865464EFQ34065677-589EADAD-7067-49DD-BA73-42BBF8FC3F77Q34252132-56A464A1-003B-4FE1-97B7-3A5958581EA3Q34287563-2A3AE331-3040-4694-AB5C-8D04C4B32441Q34465243-DC22950D-BE81-4678-AA76-70DF7B122256Q34518174-EEADB3BA-5988-4B0B-8417-D6A54B187C52Q34548875-A4DE608A-E686-4BC1-A084-1E20DC5F516AQ34663530-15DC5C6F-00BC-4F3A-8C67-150A372F0B5AQ34767787-D9FD9A4E-059A-4BD7-B2EF-9796AE4A0C63Q34911219-7F2C507E-4ED6-4481-A579-4887B74F6805Q34962838-9E38778B-A10B-4A23-8BDE-3124947769B8Q35180258-F6D243A8-D306-4E16-ADA3-CDC9A46979AAQ35185316-ED0DD0D8-86B1-4F42-AF63-659A0D32DC52Q35208791-860086A8-0F04-4FA3-AD16-A6FF9CD6A318Q35216272-5D8559BB-E3BD-46F0-B539-BDC6C2DE13BFQ35587748-5C1D776F-F91A-475C-8413-531F46E78FC4Q35605826-F3CCD986-5861-4A2D-AD38-D66D05FDF786Q35897669-9BE0F10B-B999-4E31-9FB4-B78C0D8A4F65Q35946331-DF4CA991-71CF-4B29-BA04-C3E471B19C90Q35951223-0CB447AA-1810-4F0B-83CC-9A6F28D86638
P2860
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Long-term natural history of c ...... e exacerbations and mortality.
@ast
Long-term natural history of c ...... e exacerbations and mortality.
@en
type
label
Long-term natural history of c ...... e exacerbations and mortality.
@ast
Long-term natural history of c ...... e exacerbations and mortality.
@en
prefLabel
Long-term natural history of c ...... e exacerbations and mortality.
@ast
Long-term natural history of c ...... e exacerbations and mortality.
@en
P2093
P2860
P1433
P1476
Long-term natural history of c ...... e exacerbations and mortality.
@en
P2093
Pierre Ernst
Samy Suissa
Sophie Dell'Aniello
P2860
P304
P356
10.1136/THORAXJNL-2011-201518
P407
P577
2012-06-08T00:00:00Z